TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > North Carolina Investigators

James N. Atkins, MD

Wayne Memorial Hospital, Incorporated


Goldsboro, North Carolina - 27534 (919-580-0000)

Southeastern Medical Oncology Center - ...


Goldsboro, North Carolina - 27534 (919-580-0000)

Southeastern Medical Oncology Center


Goldsboro, North Carolina - 27534
  • CLINICAL TRIALS 90
  • CONDITIONS85
  • INTERVENTIONS137
  • SINCE
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement

March 2009 - May 2015
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

April 1999 -
Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy

June 2008 - December 2009
Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors

January 2008 - June 2010
Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma

April 2008 - June 2011
Cisplatin Irinotecan and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery

February 2006 - May 2007
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

July 2009 - June 2012
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

-
Adjuvant Doxorubicin Cyclophosphamide and Paclitaxel in Treating Patients With Breast Cancer

November 2003 - June 2012
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma

May 2010 - April 2011
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery

May 2009 - December 2012
Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB Stage IIIC or Stage IV Breast Cancer

July 2008 - August 2009
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

April 2008 - January 2010
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer

June 2007 - April 2012
Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

July 2009 - February 2012
Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer

October 2008 - October 2010
Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II Stage III or Stage IV Follicular Non-Hodgkin Lymphoma

July 2010 - February 2012
Daunorubicin Cytarabine and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

April 2008 - July 2013
Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery

December 2008 - February 2011
Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720

-
Paclitaxel and Trastuzumab and/or Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

December 2008 - June 2010
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

January 2008 - May 2010
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

March 2008 - October 2008
Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II Stage III or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma

September 2005 - January 2015
Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

March 2008 - May 2012
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

August 2008 - August 2013
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB Recurrent or Persistent Cervical Cancer

April 2009 - December 2011
Using the Internet to Collect Symptoms and the Ability to Carry Out Daily Activities From Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

December 2006 -
Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced High-Risk Neuroendocrine Tumor

December 2007 - January 2012
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance Multiple Myeloma or Plasmacytoma

June 2002 -
Melphalan Prednisone and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

February 2008 - August 2009
Paclitaxel Albumin-Stabilized Nanoparticle Formulation Doxorubicin Cyclophosphamide and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer

April 2010 - June 2010
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

September 2006 - July 2008
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy

November 2008 - August 2011
Genetic Study of Patients With Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndromes or Multiple Myeloma

June 1984 - July 2005
Dinaciclib in Treating Patients With Stage IV Melanoma

July 2009 - May 2010
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage III or Stage IVA Endometrial Cancer

June 2009 - December 2013
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer

November 2007 - November 2013
Genetic Study of Familial Factors in Patients With Colon Cancer

December 2001 -
Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia or Acute Myeloid Leukemia

August 2006 - February 2008
Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma Waldenstrom's Macroglobulinemia Amyloidosis or Monoclonal Gammopathy of Undetermined Significance

November 2003 -
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

December 2008 - April 2015
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

October 2007 - September 2012
Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma

March 2005 -
Collecting Analyzing and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma

February 1989 -
Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy

October 2006 - September 2011
Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

July 2007 - November 2007
Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I Stage II or Stage IIIA Breast Cancer Undergoing Chemotherapy

September 2009 - January 2012
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia

June 2008 - December 2018
Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy

April 2010 - January 2012
Collecting and Storing Blood Bone Marrow and Other Samples From Patients With Acute Leukemia Chronic Leukemia or Myelodysplastic Syndromes

May 1996 -
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

December 2006 - September 2011
Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

December 2008 - January 2011
Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer

October 2005 - February 2008
Gemcitabine and Cisplatin in Treating Patients With Stage I Non-Small Cell Lung Cancer That Was Removed by Surgery

November 2008 - August 2009
Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer

May 2008 - February 2009
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia

May 2008 - May 2009
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II Stage IIIA or Stage IIIB Breast Cancer

July 2009 - October 2013
Single-Fraction Compared With Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases

January 2004 - June 2013
Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone

March 2007 - November 2011
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer

July 2006 - April 2024
Capecitabine Gemcitabine and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct

December 2008 - December 2010
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

November 2005 - June 2008
Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

July 1991 -
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer

May 2009 - July 2010
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative HER2-Negative Breast Cancer

May 2009 - January 2022
Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I Stage II or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection

June 2006 - December 2012
Statins and Breast Cancer Biomarkers

January 2005 - December 2010
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

April 1999 -
Bevacizumab Sorafenib and Temsirolimus in Treating Patients With Metastatic Kidney Cancer

September 2007 - May 2012
Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

December 2008 - November 2010
Iodine I 131 Tositumomab Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Stage II Stage III or Stage IV Follicular Non-Hodgkin Lymphoma

September 2008 - October 2012
Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma

September 2010 - May 2015
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma

May 2005 - March 2010
Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

April 2008 - August 2010
Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

August 2003 - July 2010
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy

June 2007 - January 2010
Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I Stage II or Stage IIIA Breast Cancer

January 2007 - January 2010
Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

November 2007 - October 2008
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

July 2009 - August 2011
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

March 2010 - January 2020
Cisplatin or Carboplatin and Etoposide With or Without Sunitinib in Treating Patients With Extensive-Stage Small Cell Lung Cancer

March 2007 - November 2011
Oxaliplatin Capecitabine Cetuximab and Radiation Therapy Followed By Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

February 2009 - December 2011
L-Arginine Supplements in Treating Women Who Are Cancer Survivors

May 2007 - May 2010
Idarubicin Cytarabine and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia

August 2009 - June 2011
Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery

July 2007 - June 2008
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

July 2010 - July 2013
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery

June 2007 - July 2015
Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial

-
Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer

March 2010 - October 2011
Breast Neoplasms

Colonic Neoplasms

Lung Neoplasms

Nervous System Neoplasms

Central Nervous System Neoplasms

Lymphoma

Lymphoma, Non-Hodgkin

Adenocarcinoma

Prostatic Neoplasms

Amyloidosis

Multiple Myeloma

Neoplasms, Plasma Cell

Leukemia

Leukemia, Lymphocytic, Chronic, B-Cell

Leukemia, Lymphoid

Neoplasms

Neoplasm Metastasis

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Leukemia, Myeloid, Acute

Leukemia, Myeloid

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Myelodysplastic Syndromes

Preleukemia

Leukemia, Myelomonocytic, Acute

Leukemia, Myelomonocytic, Chronic

Ovarian Neoplasms

Urinary Bladder Neoplasms

Carcinoma, Renal Cell

Kidney Neoplasms

Carcinoma

Fatigue

Head and Neck Neoplasms

Carcinoma, Non-Small-Cell Lung

Esophageal Diseases

Esophageal Neoplasms

Bone Neoplasms

Bone Marrow Diseases

Lymphoma, T-Cell

Melanoma

Lymphedema

Peritoneal Neoplasms

Fallopian Tube Neoplasms

Postoperative Complications

Mesothelioma

Carcinoma, Small Cell

Rectal Neoplasms

Infertility

Neurotoxicity Syndromes

Precancerous Conditions

Endometrial Neoplasms

Uterine Cervical Neoplasms

Hodgkin Disease

Myeloproliferative Disorders

Colorectal Neoplasms

Leukemia, Promyelocytic, Acute

Carcinoma, Transitional Cell

Lymphoma, Large-Cell, Immunoblastic

Neuroendocrine Tumors

Lymphoma, B-Cell

Lymphoma, Large B-Cell, Diffuse

Hematologic Neoplasms

Cholangiocarcinoma

Peripheral Nervous System Diseases

Demyelinating Diseases

Polyneuropathies

Neurologic Manifestations

Lymphoma, Follicular

Radiation Injuries

Carcinoma in Situ

Carcinoma, Intraductal, Noninfiltrating

Waldenstrom Macroglobulinemia

Carcinoma, Ductal, Breast

Lymphoma, Mantle-Cell

Gallbladder Neoplasms

Bile Duct Neoplasms

Ureteral Neoplasms

Carcinoma, Ductal

Osteonecrosis

Urologic Neoplasms

Carcinoma, Neuroendocrine

Monoclonal Gammopathies, Benign

Plasmacytoma

Paraproteinemias

Adenocarcinoma, Bronchiolo-Alveolar

Urethral Neoplasms

Placebo

Intensity-Modulated Radiation Therapy

Computed Tomography

Melphalan

Immunohistochemistry Staining Method

Laboratory Biomarker Analysis

Complementary Or Alternative Medicine Procedure

Rituximab

Zoledronic Acid

Quality-Of-Life Assessment

Filgrastim

Exercise Intervention

Educational Intervention

Study Of Socioeconomic And Demographic Variables

Assessment Of Therapy Complications

Aflibercept

Fludeoxyglucose F 18

Paclitaxel

Carboplatin

Bevacizumab

Cisplatin

Docetaxel

Fluorouracil

Leucovorin Calcium

Neoadjuvant Therapy

Therapeutic Conventional Surgery

Dasatinib

Erlotinib Hydrochloride

Gemcitabine Hydrochloride

Gene Expression Analysis

Polymorphism Analysis

Adjuvant Therapy

Cyclophosphamide

Prednisone

Radiation Therapy

Lenalidomide

Pemetrexed Disodium

Methotrexate

Methylprednisolone

Capecitabine

3-Dimensional Conformal Radiation Therapy

Oxaliplatin

Fludarabine Phosphate

Cytarabine

Doxorubicin Hydrochloride

Etoposide

Pegaspargase

Vincristine Sulfate

Temsirolimus

Bortezomib

Dexamethasone

Mercaptopurine

Polymerase Chain Reaction

Dna Methylation Analysis

Flow Cytometry

Reverse Transcriptase-Polymerase Chain Reaction

Sunitinib Malate

Vinblastine Sulfate

Goserelin

Leuprolide Acetate

Triptorelin

Microarray Analysis

Everolimus

Trastuzumab

Lapatinib Ditosylate

Pegfilgrastim

Cixutumumab

Sorafenib Tosylate

Western Blotting

Management Of Therapy Complications

Dna Analysis

Donepezil Hydrochloride

Thalidomide

Daunorubicin Hydrochloride

Thioguanine

Fluorescence In Situ Hybridization

Rosuvastatin

Conventional Surgery

Systemic Chemotherapy

Midostaurin

Azacitidine

Mutation Analysis

Cetuximab

Iodine I 131 Tositumomab

Biologic Sample Preservation Procedure

High Performance Liquid Chromatography

Study Of High Risk Factors

Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry

Doxorubicin

Tamoxifen Citrate

Irinotecan Hydrochloride

Ixabepilone

Gemtuzumab Ozogamicin

Paclitaxel Albumin-Stabilized Nanoparticle Formulation

Topotecan Hydrochloride

Pravastatin

Dacarbazine

Letrozole

Nucleic Acid Sequencing

Ac Regimen

Vandetanib

Cytogenetic Analysis

Southern Blotting

Atorvastatin

Chemotherapy

Duloxetine Hydrochloride

Idarubicin

Clinical Observation

Therapeutic Thoracoscopy

Videothoracoscopy

Therapeutic Surgical Procedure

Exemestane

Bleomycin Sulfate

Abvd Regimen

Beacopp Regimen

Procarbazine Hydrochloride

Gene Mapping

Vinorelbine Ditartrate

Entinostat

Internet-Based Intervention

Placebo Administration

Recombinant Interferon Alfa-2b

Octreotide Acetate

Epirubicin Hydrochloride

Chromosomal Translocation Analysis

Dinaciclib

Tositumomab

Acetyl-L-Carnitine Hydrochloride

Chromogenic In Situ Hybridization

Fluorescent Antibody Technique

Sentinel Lymph Node Biopsy

Active Surveillance

Axillary Lymph Node Dissection

Ultrasound Imaging

Antiandrogen Therapy

Oophorectomy

L-Arginine/Korean Ginseng/ Gingko Biloba/Damiana-Based Supplement

©2012 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo